TY  - JOUR
AU  - Montalva, Eva
AU  - Rodriguez-Peralvarez, Manuel
AU  - Blasi, Annabel
AU  - Bonanad, Santiago
AU  - Gavín, Olga
AU  - Hierro, Loreto
AU  - Llado, Laura
AU  - Llop, Elba
AU  - Pozo-Laderas, Juan Carlos
AU  - Colmenero, Jordi
PY  - 2021
DO  - 10.1097/TP.0000000000004014
UR  - http://hdl.handle.net/10668/19869
T2  - Transplantation
AB  - Anticoagulation and antiplatelet therapies are increasingly used in liver transplant (LT) candidates and recipients due to cardiovascular comorbidities, portal vein thrombosis, or to manage posttransplant complications. The implementation of the new...
LA  - en
PB  - Lippincott Williams & Wilkins
KW  - Liver transplantation
KW  - Factor Xa inhibitors
KW  - Platelet aggregation inhibitors
KW  - Waiting lists
KW  - Anesthesiologists
KW  - Anticoagulants
KW  - Hemostasis
KW  - Hemostatics
KW  - Humans
KW  - Liver transplantation
KW  - Platelet aggregation inhibitors
KW  - Thrombosis
TI  - Consensus Statement on Hemostatic Management, Anticoagulation, and Antiplatelet Therapy in Liver Transplantation.
TY  - research article
VL  - 106
ER  -